Keryx to commence phase-3 trial for Zerenex - Drug Store News PDF Print
Drug Store NewsThe company is conducting a phase-3 trial of Zerenex (ferric citrate) in patients with end-stage kidney disease on dialysis who have excessive phosphorous ...Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex ... PR Newswire (press release)Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.